0
Skip to Content
Triana Biomedicines
About
Science
Team
Publications
News
Join Us
Culture
Contact
Triana Biomedicines
About
Science
Team
Publications
News
Join Us
Culture
Contact
About
Science
Team
Publications
News
Join Us
Culture
Contact

Publications

MOLECULAR GLUES | TARGETED PROTEIN DEGRADATION | AI IN DRUG DISCOVERY

Molecular Glues:

PubMed | August 2022
1. Methods to characterize and discover molecular degraders in cells

PubMed | July 2022
2. Molecular glues: The adhesive connecting targeted protein degradation to the clinic

PubMed | March 2022
3. Emerging mechanisms of targeted protein degradation by molecular glues

PubMed | Feburary 2022
4. Defining molecular glues with a dual-nanobody cannabidiol sensor

PubMed | July 2021
5. Molecular glues for targeted protein degradation: From serendipity to rational discovery

PubMed | April 2021
6. Haven’t got a glue: Protein surface variation for the design of molecular glue degraders

PubMed | January 2021
7. The rise of molecular glues

Targeted Protein Degradation:

PubMed | March 2022
1. Driving E3 ligase substrate specificity for targeted protein degradation: Lessons from nature to the laboratory

PubMed | February 2021
2. Rationalizing PROTAC-mediated ternary complex formation using Rosetta

Annual Reviews | December 2020
3. Small-molecule approaches to targeted protein degradation

Artificial intelligence (AI) in drug discovery:

PubMed | March 2022
1. Design of protein binding proteins from target structure alone

PubMed | December 2021
2. Computed structures of core eukaryotic protein complexes

Annual Reviews | December 2019
3. Machine learning for protein folding and dynamics

TRIANA Biomedicines, Inc.

1050 Waltham Street, Suite 301
Lexington, MA 02421